• Info
  • Insider Ownership

Insider Trading & Ownership of Scott L. Burrows

Location
Waltham, MA
Summary
The estimated net worth of Scott L. Burrows is at least $5,107,054 dollars as of 03 Apr 2026. Scott L. Burrows is the Chief Financial Officer of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $4.9M. Scott L. Burrows is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $209.3K.
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Scott L. Burrows and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Scott L. Burrows has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,107,054.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Spyre Therapeutics, Inc. ($4,897,740).
  • Past-year value change for that position: -$771,335.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Scott L. Burrows

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SYRE Spyre Therapeutics, Inc. Chief Financial Officer $4,897,740 -$771,335 -14% 01 Apr 2026
ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer $209,314 06 Mar 2023

Insider Transactions Reported by Scott L. Burrows:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.